Payment overview · 2025
General Payments
$38.33
1 reported records · 1 companies
Healthcare provider profile · identity verified
Mark Alan Smith, MD
Allopathic & Osteopathic Physicians|Internal Medicine · SHERWOOD, AR · NPI 1174529887
Verified facts
What the public records show
CMS Open Payments records show Mark Alan Smith, MD received $38.33 in general payments during 2025 across 1 reported records.
Vanda Pharmaceuticals Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Vanda Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $38.33 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $38.33 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FANAPT Normalized: fanapt |
Drug | Vanda Pharmaceuticals Inc. | $38.33 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Gabapentin | Gabapentin | 537 | 91 |
| Atorvastatin Calcium | Atorvastatin Calcium | 508 | 82 |
| Levothyroxine Sodium | Levothyroxine Sodium | 450 | 80 |
| Lisinopril | Lisinopril | 374 | 51 |
| Amlodipine Besylate | Amlodipine Besylate | 331 | 61 |
| Furosemide | Furosemide | 304 | 61 |
| Potassium Chloride | Potassium Chloride | 292 | 53 |
| Trazodone Hcl | Trazodone Hcl | 275 | 49 |
| Mirtazapine | Mirtazapine | 267 | 53 |
| Pantoprazole Sodium | Pantoprazole Sodium | 256 | 53 |
| Metoprolol Tartrate | Metoprolol Tartrate | 248 | 41 |
| Donepezil Hcl | Donepezil Hcl | 231 | 42 |
| Losartan Potassium | Losartan Potassium | 211 | 38 |
| Eliquis | Apixaban | 207 | 44 |
| Metoprolol Succinate | Metoprolol Succinate | 201 | 34 |
| Escitalopram Oxalate | Escitalopram Oxalate | 199 | 29 |
| Omeprazole | Omeprazole | 185 | 30 |
| Sertraline Hcl | Sertraline Hcl | 185 | 33 |
| Metformin Hcl | Metformin Hcl | 183 | 31 |
| Clopidogrel | Clopidogrel Bisulfate | 154 | 22 |
| Pravastatin Sodium | Pravastatin Sodium | 150 | 23 |
| Famotidine | Famotidine | 149 | 34 |
| Duloxetine Hcl | Duloxetine Hcl | 147 | 18 |
| Tamsulosin Hcl | Tamsulosin Hcl | 145 | 26 |
| Glipizide | Glipizide | 142 | 20 |
| Quetiapine Fumarate | Quetiapine Fumarate | 138 | 22 |
| Carvedilol | Carvedilol | 136 | 23 |
| Memantine Hcl | Memantine Hcl | 115 | 19 |
| Tizanidine Hcl | Tizanidine Hcl | 112 | 29 |
| Levofloxacin | Levofloxacin | 100 | 66 |
| Simvastatin | Simvastatin | 100 | 19 |
| Hydralazine Hcl | Hydralazine Hcl | 96 | 19 |
| Meloxicam | Meloxicam | 94 | 41 |
| Buspirone Hcl | Buspirone Hcl | 92 | 19 |
| Allopurinol | Allopurinol | 86 | 15 |
| Divalproex Sodium | Divalproex Sodium | 85 | 17 |
| Fluticasone Propionate | Fluticasone Propionate | 83 | 22 |
| Olanzapine | Olanzapine | 81 | 12 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 79 | 29 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 79 | suppressed |
| Risperidone | Risperidone | 78 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 73 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 71 | 13 |
| Montelukast Sodium | Montelukast Sodium | 69 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 68 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 67 | 12 |
| Entresto | Sacubitril/Valsartan | 66 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 65 | 48 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 60 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 59 | suppressed |
| Methylprednisolone | Methylprednisolone | 57 | 38 |
| Novolin R | Insulin Regular, Human | 55 | 18 |
| Atenolol | Atenolol | 52 | suppressed |
| Fluconazole | Fluconazole | 49 | 32 |
| Methenamine Hippurate | Methenamine Hippurate | 49 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 48 | 14 |
| Breo Ellipta | Fluticasone/Vilanterol | 46 | suppressed |
| Ezetimibe | Ezetimibe | 46 | suppressed |
| Humulin R | Insulin Regular, Human | 46 | 17 |
| Propranolol Hcl | Propranolol Hcl | 46 | suppressed |
| Azithromycin | Azithromycin | 44 | 25 |
| Dicyclomine Hcl | Dicyclomine Hcl | 44 | suppressed |
| Levetiracetam | Levetiracetam | 41 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 41 | suppressed |
| Brilinta | Ticagrelor | 40 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 40 | 31 |
| Alcohol Swabs | Alcohol Antiseptic Pads | 39 | suppressed |
| Cefdinir | Cefdinir | 37 | 20 |
| Fenofibrate | Fenofibrate Nanocrystallized | 37 | suppressed |
| Gemtesa | Vibegron | 37 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 37 | 23 |
| Pioglitazone Hcl | Pioglitazone Hcl | 36 | suppressed |
| Spironolactone | Spironolactone | 36 | suppressed |
| Sucralfate | Sucralfate | 36 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 35 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 35 | suppressed |
| Bumetanide | Bumetanide | 34 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 34 | suppressed |
| Alprazolam | Alprazolam | 33 | suppressed |
| Xarelto | Rivaroxaban | 33 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 32 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 31 | 21 |
| Glimepiride | Glimepiride | 31 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 31 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 31 | 25 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 29 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 28 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 27 | suppressed |
| Pregabalin | Pregabalin | 27 | suppressed |
| Finasteride | Finasteride | 26 | suppressed |
| Lamotrigine | Lamotrigine | 26 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 25 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 25 | 11 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 25 | suppressed |
| Verapamil Er | Verapamil Hcl | 25 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 25 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 24 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 24 | suppressed |
| Nifedipine Er | Nifedipine | 24 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 24 | suppressed |
| Timolol Maleate | Timolol Maleate | 24 | suppressed |
| Jardiance | Empagliflozin | 23 | suppressed |
| Lorazepam | Lorazepam | 23 | 13 |
| Nystatin | Nystatin | 23 | 15 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 22 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 22 | 11 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 22 | 12 |
| Latanoprost | Latanoprost | 22 | suppressed |
| Prednisone | Prednisone | 22 | suppressed |
| Chlorthalidone | Chlorthalidone | 21 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 21 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 20 | suppressed |
| Ozempic | Semaglutide | 20 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 20 | suppressed |
| Acyclovir | Acyclovir | 19 | suppressed |
| Primidone | Primidone | 19 | suppressed |
| Ranolazine Er | Ranolazine | 19 | suppressed |
| Baclofen | Baclofen | 18 | suppressed |
| Bupropion Xl | Bupropion Hcl | 18 | suppressed |
| Cephalexin | Cephalexin | 18 | 12 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 18 | 17 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 18 | suppressed |
| Eszopiclone | Eszopiclone | 17 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 17 | suppressed |
| Sulfasalazine | Sulfasalazine | 17 | suppressed |
| Digoxin | Digoxin | 16 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 16 | suppressed |
| Torsemide | Torsemide | 16 | suppressed |
| Januvia | Sitagliptin Phosphate | 15 | suppressed |
| Ondansetron Odt | Ondansetron | 15 | suppressed |
| Erythromycin | Erythromycin Base | 14 | suppressed |
| Leflunomide | Leflunomide | 14 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 14 | 14 |
| Prazosin Hcl | Prazosin Hcl | 14 | suppressed |
| Estradiol | Estradiol | 13 | suppressed |
| Myrbetriq | Mirabegron | 13 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 13 | 12 |
| Tresiba Flextouch U-100 | Insulin Degludec | 13 | suppressed |
| Alcohol Swab | Alcohol Antiseptic Pads | 12 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 12 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 12 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 12 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Glipizide Er | Glipizide | 12 | suppressed |
| Irbesartan | Irbesartan | 12 | suppressed |
| Letrozole | Letrozole | 12 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 12 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 12 | suppressed |
| Aripiprazole | Aripiprazole | 11 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $38.33 · 1 records | Vanda Pharmaceuticals Inc. | FANAPT | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error